References
- Kihara T, Shimohama S. Alzheimer’s disease and acetylcholine receptors. Acta Neurobiol Exp (Wars) 2004;64:99–105.
- Inestrosa NC, Alvarez A, Calderon F. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer’s filaments. Mol Psychiatry 1996;1:359–61.
- McGleenon BM, Dynan KB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer’s disease. Br J Clin Pharmacol 1999;48:471–80.
- Taylor P. Development of acetylcholinesterase inhibitors in the therapy of Alzheimer’s disease. Neurology 1998;1(Suppl 1):S30–5; discussion S65–7.
- Castro A, Martinez A. Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer’s disease. Mini Rev Med Chem 2001;1:267–72.
- Saltmarsh JR, Boyd AE, Rodriguez OP, Radić Z, Taylor P, Thompson CM. Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase. Bioorg Med Chem Lett 2000;10:1523–6.
- Liu Y, Patricelli MP, Cravatt BF. Activity-based protein profiling: the serine hydrolases. Proc Natl Acad Sci USA 1999;96:14694–9.
- Cravatt BF, Sorensen EJ. Chemical strategies for the global analysis of protein function. Curr Opin Chem Biol 2000;4:663–8.
- Kucukkilinc T, Ozer I. Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine fluorophores. Arch Biochem Biophys 2007;461:294–8.
- Kucukkilinc T, Ozer I. Inhibition of electric eel acetylcholinesterase by triarylmethane fluorophores. Chem Biol Interact 2008;175:309–11.
- Kang JJ, Fang HW. Polycyclic aromatic hydrocarbons inhibit the activity of acetylcholinesterase purified from electric eel. Biochem Biophys Res Commun 1997;238:367–9.
- Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 2001;40:2004–21.
- Rostovtsev VV, Green LG, Fokin VV, Sharpless KB. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes. Angew Chem Int Ed Engl 2002;41:2596–9.
- Marchot P, Ravelli RB, Raves ML, Bourne Y, Vellom DC, Kanter J, et al. Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin. Protein Sci 1996;5:672–9.
- Bolletta F, Fabbri D, Lombardo M, Prodi L, Trombini C, Zaccheroni N. Synthesis and photophysical properties of fluorescent derivatives of methylmercury. Organometallics 1996;15:2415–17.
- Lewis WG, Magallon FG, Fokin VV, Finn MG. Discovery and characterization of catalysts for azide-alkyne cycloaddition by fluorescence quenching. J Am Chem Soc 2004;126:9152–3.
- Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
- Bartolucci C, Siotto M, Ghidini E, Amari G, Bolzoni PT, Racchi M, et al. Structural determinants of Torpedo Californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-Alzheimer drug ganstigmine (CHF-2819) J Med Chem 2006;49:5051–8.
- Doucet-Personeni C, Bentley PD, Fletcher RJ, Kinkaid A, Kryger G, Pirard B, et al. A structure-based design approach to the development of novel, reversible AChE inhibitors. J Med Chem 2001;44:3203–15.
- Millard CB, Kryger G, Ordentlich A, Greenblatt HM, Harel M, Raves ML, et al. Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. Biochemistry 1999;38:7032–9.